fully independent intellectual property rights of minimally invasive medical technology companies, and patented technology in the international leading position.R & D team is composed of cardiac surgeon Dr. Zhang Ji and a number of senior foreign professionals. The company's leading project is the development of innovative precision positioning heart valve implantation system technology and product development.
The precise positioning system of heart valve implantation is a minimally invasive surgical technique, without thoracotomy, without extracorporeal blood circulation, can significantly reduce surgical trauma, shorten the patient's postoperative recovery time, reduce pain, reduce the patient's body condition, thereby expanding the range of indications, improve the therapeutic effect, reduce the the cost of surgery, the most in need of replacement heart valve patients can get treatment. This technology will change the traditional mode of operation, easier to operate and master, can simplify the process of heart valve replacement, reduce the doctor's requirements. Other similar products will require a doctor within the human heart valve implantation through the imaging ability, while products can completely rely on their own system of implant positioning device to complete the valve replacement operation, thereby reducing the risk of surgery, so that patients receive timely treatment. These advantages will help to reduce the overall cost of the national health care system, promote the reform of the medical system, reduce medical costs, save medical resources of the society, it will completely change the long-term dependence on imports of heart valve situation, help China minimally invasive medical technology to the world. In addition, the company will consolidate the existing advanced medical device research and development platform and production base for other related products R & D foundation.